C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis.

Abstract:

:The proto-oncogene, c-src, has been implicated in the tumorigenesis in breast cancer. However, the relationship of c-src with distant metastasis is unclear. Moreover, the role of c-src in organ-preferential metastasis of breast cancer is unknown. Because breast cancer has a strong predilection for metastasizing to bone, we examined the role of c-src in bone metastases using an animal model in which inoculation of the MDA-231 human breast cancer cells into the left cardiac ventricle preferentially developed osteolytic bone metastases in female nude mice. A clone of the MDA-231 with the increased capacity of bone metastasis exhibited elevated c-src tyrosine kinase (TK) activity compared with parental cells. MDAsrc527 cells caused significantly increased size of the osteolytic bone metastases with increased number of osteoclasts and mitotic cancer cells compared with MDA-231EV or MDAsrcWT. In contrast, MDAsrc295 cells caused impaired metastases to bone. Of note, mice inoculated with MDAsrc295 cells via tail vein developed reduced lung metastases and prolonged survival compared with mice with MDA-231EV cells, suggesting that c-src TK is unlikely to play a specific role in bone metastases. The growth in vitro and in vivo and production of parathyroid hormone-related protein, a key cytokine in the pathogenesis of osteolytic bone metastases in breast cancer, were promoted in MDAsrc527 and diminished in MDAsrc295. These results suggest that c-src TK is associated with the capacity of breast cancer to metastasize to bone through regulating cell growth and parathyroid hormone-related protein production. Our results together with the fact that c-src is an essential molecule for bone resorption by osteoclasts, which are central players in osteolytic bone metastases, support the notion that c-src TK is a potential target molecule for designing novel therapeutic interventions, especially for bone metastases in breast cancer.

journal_name

Cancer Res

journal_title

Cancer research

authors

Myoui A,Nishimura R,Williams PJ,Hiraga T,Tamura D,Michigami T,Mundy GR,Yoneda T

subject

Has Abstract

pub_date

2003-08-15 00:00:00

pages

5028-33

issue

16

eissn

0008-5472

issn

1538-7445

journal_volume

63

pub_type

杂志文章
  • Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a.

    abstract::Activated ras oncogene transfection into suitable recipient cells has been shown to induce the metastatic phenotype (Thorgeirsson, et al., Mol. Cell. Biol., 5: 259-262, 1985). We have used this model system to study the correlation of basement membrane collagenolysis with metastatic propensity. The c-Ha-ras oncogene a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Garbisa S,Pozzatti R,Muschel RJ,Saffiotti U,Ballin M,Goldfarb RH,Khoury G,Liotta LA

    更新日期:1987-03-15 00:00:00

  • Low mitochondrial proton leak due to high membrane cholesterol content and cytosolic creatine kinase as two features of the deviant bioenergetics of Ehrlich and AS30-D tumor cells.

    abstract::Isolated mitochondria from highly glycolytic Ehrlich and AS30-D tumor cells have a 12.4- and a 2.3-fold higher cholesterol level, respectively, than that of rat liver mitochondria. The passive proton permeability of Ehrlich and AS30-D tumor inner membrane mitochondria is, respectively, 4- and 1.4-fold lower than that ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Baggetto LG,Clottes E,Vial C

    更新日期:1992-09-15 00:00:00

  • The EWS protein is dispensable for Ewing tumor growth.

    abstract::EWS encodes a ubiquitously expressed RNA binding protein with largely unknown function. In Ewing sarcoma family tumors (EFT), one allele is rearranged with an ETS gene. This is the first description of an EFT with a complete EWS deficiency in the presence of two copies of a rearranged chromosome 22 carrying an interst...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kovar H,Jug G,Hattinger C,Spahn L,Aryee DN,Ambros PF,Zoubek A,Gadner H

    更新日期:2001-08-15 00:00:00

  • Thymidine phosphorylase expression is associated with both increase of intratumoral microvessels and decrease of apoptosis in human colorectal carcinomas.

    abstract::Thymidine phosphorylase (dThdPase)/platelet-derived endothelial cell growth factor is expressed at higher levels in a variety of human carcinomas than it is in adjacent normal tissue. The higher expression is associated with an increase of intratumoral microvessel density (IMVD) and an unfavorable patient prognosis. W...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Matsuura T,Kuratate I,Teramachi K,Osaki M,Fukuda Y,Ito H

    更新日期:1999-10-01 00:00:00

  • VEGFC Antibody Therapy Drives Differentiation of AML.

    abstract::High expression of VEGFC predicts adverse prognosis in acute myeloid leukemia (AML). We therefore explored VEGFC-targeting efficacy as an AML therapy using a VEGFC mAb. VEGFC antibody therapy enforced myelocytic differentiation of clonal CD34+ AML blasts. Treatment of CD34+ AML blasts with the antibody reduced expansi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-0250

    authors: Kampen KR,Scherpen FJG,Mahmud H,Ter Elst A,Mulder AB,Guryev V,Verhagen HJMP,De Keersmaecker K,Smit L,Kornblau SM,De Bont ESJM

    更新日期:2018-10-15 00:00:00

  • Antineuroblastoma activity of desferoxamine in human cell lines.

    abstract::That ferritin, an iron storage protein, can be produced by neuroblastoma cells raises the possibility that iron may have some role in promoting tumor cell growth. To explore this possibility, we studied the effects of desferoxamine, a compound which chelates iron, on viability of CHP 126 and CHP 100, two human neurobl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Blatt J,Stitely S

    更新日期:1987-04-01 00:00:00

  • Coupling of mutated Met variants to DNA repair via Abl and Rad51.

    abstract::Abnormal activation of DNA repair pathways by deregulated signaling of receptor tyrosine kinase systems is a compelling likelihood with significant implications in both cancer biology and treatment. Here, we show that due to a potential substrate switch, mutated variants of the receptor for hepatocyte growth factor Me...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1269

    authors: Ganapathipillai SS,Medová M,Aebersold DM,Manley PW,Berthou S,Streit B,Blank-Liss W,Greiner RH,Rothen-Rutishauser B,Zimmer Y

    更新日期:2008-07-15 00:00:00

  • Inhibitory effect of antibody against basic fibroblast growth factor on androgen- or glucocorticoid-induced growth of Shionogi carcinoma 115 cells in serum-free culture.

    abstract::Shionogi carcinoma 115 (SC115) has been accepted for 20 years as an androgen-responsive mouse mammary tumor. However, we and others recently found that the growth of SC115 cells is also stimulated by high doses of glucocorticoids. We already reported the following findings. In a serum-free medium [Ham's F-12: Eagle's ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lu J,Nishizawa Y,Tanaka A,Nonomura N,Yamanishi H,Uchida N,Sato B,Matsumoto K

    更新日期:1989-09-15 00:00:00

  • A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma.

    abstract::Interleukin-6 (IL-6) is a pleiotropic cytokine with a broad range of physiologic and pathologic functions. Because in cancer, IL-6 contributes to a microenvironment that promotes tumor cell survival, angiogenesis, and inflammation, understanding the mechanism responsible for its production is important. In neuroblasto...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-2165

    authors: Silverman AM,Nakata R,Shimada H,Sposto R,DeClerck YA

    更新日期:2012-05-01 00:00:00

  • NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma.

    abstract::Chimeric antigen receptor (CAR) T-cell therapy is an emerging immunotherapy against several malignancies including glioblastoma, the most common and most aggressive malignant primary brain tumor in adults. The challenges in solid tumor immunotherapy comprise heterogenously expressed tumor target antigens and restricte...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-1788

    authors: Weiss T,Weller M,Guckenberger M,Sentman CL,Roth P

    更新日期:2018-02-15 00:00:00

  • An early event associated with liver carcinogenesis involving loss of a polypeptide that binds carcinogen.

    abstract::This report describes an early and direct action of oncogenic agents and its apparent consequences. Chemical carcinogen has been found to interact principally with a specific polypeptide in livers of normal rats. Short-term ingestion of carcinogen causes marked reductions in the concentrations of both the carcinogen:p...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Blackburn GR,Andrews JP,Rao KV,Sorof S

    更新日期:1980-12-01 00:00:00

  • Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro.

    abstract::c-myc expression, amplification, and rearrangement were studied in neoplastic hepatic nodules of rats after diethylnitrosamine treatment, in hepatocellular carcinomas induced by N-methyl-N-nitrosourea, and in tumorigenic liver cell lines derived from rat hepatocytes transformed by diethylnitrosamine in vivo. Steady-st...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Suchy BK,Sarafoff M,Kerler R,Rabes HM

    更新日期:1989-12-01 00:00:00

  • Different modifying response of butylated hydroxyanisole, butylated hydroxytoluene, and other antioxidants in N,N-dibutylnitrosamine esophagus and forestomach carcinogenesis of rats.

    abstract::The modifying effects of antioxidants were examined in a carcinogenesis system after N,N-dibutylnitrosamine treatment. Male F344 rats were given 0.05% N,N-dibutylnitrosamine in their drinking water for 4 wk and then treated with basal diet containing 2% butylated hydroxyanisole (BHA), 1% butylated hydroxytoluene (BHT)...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fukushima S,Sakata T,Tagawa Y,Shibata MA,Hirose M,Ito N

    更新日期:1987-04-15 00:00:00

  • Molecular cloning of the chromosomal breakpoint of a B-cell lymphoma with the t(11;14)(q23;q32) translocation.

    abstract::The breakpoint of t(11;14)(q23;q32) chromosome translocation in a B-cell lymphoma line, RC-K8, was cloned. Immunoglobulin heavy chain (IGH) constant gene, C gamma 2 at the 5' end, was involved in this translocation, and the DNA segment juxtaposed to the C gamma 2 was proved to be derived from chromosome 11 by somatic ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Akao Y,Seto M,Takahashi T,Kubonishi I,Miyoshi I,Nakazawa S,Tsujimoto Y,Croce CM,Ueda R

    更新日期:1991-03-01 00:00:00

  • Alterations of choline phospholipid metabolism in ovarian tumor progression.

    abstract::Recent characterization of abnormal phosphatidylcholine metabolism in tumor cells by nuclear magnetic resonance (NMR) has identified novel fingerprints of tumor progression that are potentially useful as clinical diagnostic indicators. In the present study, we analyzed the concentrations of phosphatidylcholine metabol...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1146

    authors: Iorio E,Mezzanzanica D,Alberti P,Spadaro F,Ramoni C,D'Ascenzo S,Millimaggi D,Pavan A,Dolo V,Canevari S,Podo F

    更新日期:2005-10-15 00:00:00

  • Inhibition of human malignant neuroblastoma cell DNA synthesis by lipoxygenase metabolites of arachidonic acid.

    abstract::In vivo studies have shown that inhibitors of cyclooxygenase metabolism of arachidonic acid may diminish growth and metastasis of certain tumors. Because cyclooxygenase inhibition may increase the production of lipoxygenase products of arachidonic acid metabolism, we have investigated the effect of two such products, ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Werner EJ,Walenga RW,Dubowy RL,Boone S,Stuart MJ

    更新日期:1985-02-01 00:00:00

  • Tumor-caused changes in host protein synthesis under different dietary situations.

    abstract::The effect of the AC33 tumor on protein synthesis in Lewis-Wistar rats was investigated under four different dietary regimens. The four diets used were: (a) 1.25 g amino acids plus 12.5 g glucose per day, (b) 1.25 g amino acids, (c) 1.25 g glucose per day, and (d) 12.5 g glucose per day. The rats were maintained on th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Stein TP,Oram-Smith JC,Leskiw MJ,Wallace HW,Miller EE

    更新日期:1976-11-01 00:00:00

  • Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.

    abstract::Mucin 1 (MUC1), a bound mucin glycoprotein, is overexpressed and aberrantly glycosylated in >80% of human ductal pancreatic carcinoma. Evidence suggests that MUC1 can be used as a tumor marker and is a potential target for immunotherapy of pancreatic cancer. However, vaccination with MUC1 peptides fails to stimulate t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-4313

    authors: Deguchi T,Tanemura M,Miyoshi E,Nagano H,Machida T,Ohmura Y,Kobayashi S,Marubashi S,Eguchi H,Takeda Y,Ito T,Mori M,Doki Y,Sawa Y

    更新日期:2010-07-01 00:00:00

  • Targeting leukemia-initiating cells in acute lymphoblastic leukemia (ALL).

    abstract::The concept that different leukemias are developmentally distinct and, like in normal hematopoiesis, generated by restricted populations of cells named leukemia-initiating cells (LIC), is becoming more established. These cancer stem-like cells have been assumed to have unique properties, including the capability of se...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-20-2571

    authors: Tamiro F,Weng AP,Giambra V

    更新日期:2021-01-07 00:00:00

  • SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.

    abstract::Activation of the matrix metalloproteinase 2 (MMP-2) has been shown to play a major role in the proteolysis of extracellular matrix (ECM) associated with tumor invasion. Although the precise mechanism of this activation remains elusive, levels of the membrane type 1-MMP (MT1-MMP) at the cell surface and of the tissue ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gilles C,Bassuk JA,Pulyaeva H,Sage EH,Foidart JM,Thompson EW

    更新日期:1998-12-01 00:00:00

  • miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis.

    abstract::Malignant glioma is an often fatal type of cancer. Aberrant activation of STAT3 leads to glioma tumorigenesis. STAT3-induced transcription of protein-coding genes has been extensively studied; however, little is known about STAT3-regulated miRNA gene transcription in glioma tumorigenesis. In this study, we found that ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-15-3073

    authors: Xue J,Zhou A,Wu Y,Morris SA,Lin K,Amin S,Verhaak R,Fuller G,Xie K,Heimberger AB,Huang S

    更新日期:2016-07-15 00:00:00

  • Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia.

    abstract::LMO2 is a transcription regulator involved in human T-cell leukemia, including some occurring in X-SCID gene therapy trials, and in B-cell lymphomas and prostate cancer. LMO2 functions in transcription complexes via protein-protein interactions involving two LIM domains and causes a preleukemic T-cell development bloc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-4774

    authors: Appert A,Nam CH,Lobato N,Priego E,Miguel RN,Blundell T,Drynan L,Sewell H,Tanaka T,Rabbitts T

    更新日期:2009-06-01 00:00:00

  • Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands.

    abstract::Epidemiological studies have shown a positive association of colon cancer with hyperlipidemia. Furthermore, signaling generated by peroxisome proliferator-activated receptor (PPAR) alpha and gamma ligands, suggested to be candidate tumor preventive agents, has been shown to lower serum triglyceride levels. In the pres...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Niho N,Takahashi M,Kitamura T,Shoji Y,Itoh M,Noda T,Sugimura T,Wakabayashi K

    更新日期:2003-09-15 00:00:00

  • Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction.

    abstract::The presence of tumor cells in the circulation may predict disease recurrence and metastases. We have developed a sensitive technique for the detection of carcinoma cells in blood, using immunomagnetic beads to enrich for epithelial cells and the polymerase chain reaction to identify a tumor marker. The colon carcinom...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hardingham JE,Kotasek D,Farmer B,Butler RN,Mi JX,Sage RE,Dobrovic A

    更新日期:1993-08-01 00:00:00

  • Multiomics characterization of low-grade serous ovarian carcinoma identifies potential biomarkers of MEK inhibitor sensitivity and therapeutic vulnerability.

    abstract::Low-grade serous ovarian carcinoma (LGSOC) is a rare tumor subtype with high case fatality rates in patients with metastatic disease. There is a pressing need to develop effective treatments using newly available preclinical models for therapeutic discovery and drug evaluation. Here we use multiomics integration of wh...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-20-2222

    authors: Shrestha R,Llaurado Fernandez M,Dawson A,Hoenisch J,Volik S,Lin YY,Anderson S,Kim H,Haegert AM,Colborne S,Wong NKY,McConeghy B,Bell RH,Brahmbhatt S,Lee CH,DiMattia GE,Le Bihan S,Morin GB,Collins CC,Carey MS

    更新日期:2021-01-13 00:00:00

  • Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.

    abstract::Acquired resistance to cisplatin has been generated in vitro in two human ovarian carcinoma cell lines: 41M, established from a previously untreated patient; and CH1, from a patient previously treated with cisplatin and cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II) (carboplatin). In neither cell line with acq...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kelland LR,Mistry P,Abel G,Loh SY,O'Neill CF,Murrer BA,Harrap KR

    更新日期:1992-07-15 00:00:00

  • Fas-mediated apoptosis in human prostatic carcinoma cell lines.

    abstract::Of six prostatic carcinoma cell lines examined (ALVA31, DU145, JCA1, LNCaP, ND1, and PC3) by flow cytometric analysis, all were found to be positive for Fas antigen. Furthermore, of the prostate tissue specimens studied (six cases), all revealed Fas expression in benign and malignant epithelial cells. The agonistic an...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rokhlin OW,Bishop GA,Hostager BS,Waldschmidt TJ,Sidorenko SP,Pavloff N,Kiefer MC,Umansky SR,Glover RA,Cohen MB

    更新日期:1997-05-01 00:00:00

  • Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis.

    abstract::Although mutated forms of ras are not associated with the majority of breast cancers (<5%), there is considerable experimental evidence that hyperactive Ras can promote breast cancer growth and development. Therefore, we determined whether Ras and Ras-responsive signaling pathways were activated persistently in nine w...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-0396

    authors: Eckert LB,Repasky GA,Ulkü AS,McFall A,Zhou H,Sartor CI,Der CJ

    更新日期:2004-07-01 00:00:00

  • Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer.

    abstract::Triple-negative breast cancer (TNBC) is an aggressive clinical subtype accounting for up to 20% of all breast cancers, but its malignant determinants remain largely undefined. Here, we show that in TNBC the overexpression of Fra-1, a component of the transcription factor AP-1, offers prognostic potential. Fra-1 deplet...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-3396

    authors: Zhao C,Qiao Y,Jonsson P,Wang J,Xu L,Rouhi P,Sinha I,Cao Y,Williams C,Dahlman-Wright K

    更新日期:2014-07-15 00:00:00

  • Differential cell photosensitivity following porphyrin photodynamic therapy.

    abstract::Experiments were performed to determine if differences in porphyrin photosensitivity could be observed for cells with varying efficiency in DNA damage repair, as well as for cells which make up components of the vasculature. Photofrin II is undergoing current clinical evaluation for photodynamic therapy of solid tumor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gomer CJ,Rucker N,Murphree AL

    更新日期:1988-08-15 00:00:00